Hallucinogenic herb a problem in Wash.

Feb 26, 2007

Both Washington state and U.S. officials are growing increasingly concerned over the popularity of a legal hallucinogenic herb in the region around Seattle.

An herb from the mint family, Salvia Divinorum has become a popular drug of choice with many Washington teenagers and its reported ability to make its users hallucinate and forget has many officials concerned, Seattle's KIRO-TV reported.

"Just because it's legal, just because it's not classified, just because it's not a controlled substance doesn't mean that it's healthy and safe," DEA official Rodney Benson said.

The herb, whose origins are in Mexican spiritual ceremonies, has already been linked to the suicide of a teen in Delaware, prompting officials there to ban the hallucinogen.

Benson said with the herb growing in popularity in the suburbs of Seattle, scientists are working quickly on determining if the herb should be deemed a controlled substance.

Until that decision can be made and authorities can act, Benson told the TV station area parents should inform their children of potential risks, including violent behavior and hallucinations.

Copyright 2007 by United Press International

Explore further: Cardinal Health paying $26.8 million in FTC settlement

Related Stories

How to alert drivers to fatigue

25 minutes ago

Frank Black is a professional truck driver, having clocked up nearly three decades travelling the breadth of Australia. But every time he gets into his cab, Black thinks about driver fatigue; over the years ...

Killer bees test a double win for Australian honeybees

35 minutes ago

A genetic test that can prevent the entry of 'killer' bees into Australia and worldwide spread has been created by researchers at the University of Sydney and their collaborators at York University in Canada.

Rising carbon dioxide levels stunt sea shell growth

35 minutes ago

Scientists have discovered that stunted growth can be a genetic response to ocean acidification, enabling some sea creatures to survive high carbon dioxide levels, both in the future and during past mass ...

Protecting our rights to privacy and digital dignity

37 minutes ago

How many of us read the terms and conditions when signing up to a social media account or downloading a new app? And does agreeing to these rules offer us any real protection from big business looking to ...

Recommended for you

Cardinal Health paying $26.8 million in FTC settlement

17 hours ago

Cardinal Health will pay $26.8 million as part of a settlement with the Federal Trade Commission over charges it monopolized the sale in 25 markets of diagnostic drugs known as low-energy radiopharmaceuticals.

Selecting the right tool for the job

Apr 14, 2015

Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.